Danaher Co. (NYSE:DHR) Holdings Lifted by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC grew its position in Danaher Co. (NYSE:DHRFree Report) by 237.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,606 shares of the conglomerate’s stock after purchasing an additional 1,833 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Danaher were worth $657,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in DHR. GPS Wealth Strategies Group LLC acquired a new stake in shares of Danaher in the 1st quarter worth approximately $25,000. Freedom Wealth Alliance LLC acquired a new stake in Danaher during the fourth quarter valued at approximately $27,000. Chelsea Counsel Co. acquired a new stake in Danaher during the fourth quarter valued at approximately $27,000. My Personal CFO LLC acquired a new stake in Danaher during the fourth quarter valued at approximately $29,000. Finally, Private Ocean LLC lifted its stake in Danaher by 1,485.7% during the fourth quarter. Private Ocean LLC now owns 111 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 104 shares during the last quarter. 75.68% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Danaher

In related news, SVP Daniel Raskas sold 19,847 shares of the company’s stock in a transaction dated Wednesday, May 31st. The shares were sold at an average price of $228.50, for a total value of $4,535,039.50. Following the sale, the senior vice president now owns 38,673 shares of the company’s stock, valued at $8,836,780.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Danaher news, SVP Jose-Carlos Gutierrez-Ramos sold 500 shares of Danaher stock in a transaction on Monday, May 1st. The stock was sold at an average price of $242.19, for a total value of $121,095.00. Following the completion of the transaction, the senior vice president now owns 7,529 shares in the company, valued at approximately $1,823,448.51. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Daniel Raskas sold 19,847 shares of the stock in a transaction on Wednesday, May 31st. The stock was sold at an average price of $228.50, for a total value of $4,535,039.50. Following the sale, the senior vice president now owns 38,673 shares in the company, valued at approximately $8,836,780.50. The disclosure for this sale can be found here. Insiders have sold a total of 34,466 shares of company stock valued at $8,103,781 over the last quarter. 11.10% of the stock is owned by company insiders.

Analyst Ratings Changes

Several analysts recently commented on DHR shares. Royal Bank of Canada cut their target price on shares of Danaher from $289.00 to $260.00 in a research note on Wednesday, April 26th. StockNews.com started coverage on shares of Danaher in a research note on Thursday, May 18th. They set a “buy” rating for the company. Credit Suisse Group cut their target price on shares of Danaher from $300.00 to $270.00 in a research note on Wednesday, April 26th. Stifel Nicolaus reduced their price target on shares of Danaher from $270.00 to $250.00 in a research report on Wednesday, April 26th. Finally, Wells Fargo & Company upgraded shares of Danaher from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $275.00 to $285.00 in a research report on Tuesday, April 18th. Three investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus price target of $294.88.

Danaher Stock Up 0.2 %

Danaher stock opened at $238.15 on Thursday. The firm has a fifty day moving average price of $234.67 and a two-hundred day moving average price of $247.77. Danaher Co. has a fifty-two week low of $221.22 and a fifty-two week high of $303.82. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.89 and a quick ratio of 1.51. The firm has a market cap of $175.73 billion, a price-to-earnings ratio of 25.66, a P/E/G ratio of 2.35 and a beta of 0.80.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings data on Tuesday, April 25th. The conglomerate reported $2.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.26 by $0.10. Danaher had a net margin of 22.40% and a return on equity of 16.70%. The company had revenue of $7.17 billion for the quarter, compared to the consensus estimate of $7.06 billion. During the same quarter in the previous year, the firm posted $2.76 EPS. The business’s revenue was down 6.8% compared to the same quarter last year. As a group, analysts forecast that Danaher Co. will post 9.43 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Investors of record on Friday, June 30th will be paid a $0.27 dividend. The ex-dividend date is Thursday, June 29th. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. Danaher’s payout ratio is currently 11.64%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.